Boston Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$840K Sell
42,365
-2,848
-6% -$59.3K 0.04% 404
2019
Q2
$954K Sell
45,213
-397
-0.9% -$8.3K 0.05% 366
2019
Q1
$932K Sell
45,610
-2,551
-5% -$57.2K 0.05% 356
2018
Q4
$958K Buy
48,161
+3,945
+9% +$77.8K 0.06% 321
2018
Q3
$851K Buy
44,216
+2,268
+5% +$40.4K 0.04% 407
2018
Q2
$640K Sell
41,948
-705
-2% -$12.3K 0.02% 454
2018
Q1
$800K Buy
42,653
+2,733
+7% +$51.4K 0.02% 409
2017
Q4
$768K Buy
39,920
+1,025
+3% +$19.1K 0.02% 422
2017
Q3
$695K Buy
38,895
+3,635
+10% +$59.8K 0.02% 426
2017
Q2
$630K Sell
35,260
-2,080
-6% -$33K 0.01% 445
2017
Q1
$541K Buy
37,340
+6,700
+22% +$105K 0.01% 450
2016
Q4
$564K Buy
30,640
+14,735
+93% +$287K 0.01% 455
2016
Q3
$302K Buy
+15,905
New +$289K 0.01% 607

Other funds holding AMPH